申请人:INSTITUT NATIONAL DE LA SANTE ET DE LA
RECHERCHE MEDICALE (INSERM)
公开号:EP1411041A1
公开(公告)日:2004-04-21
The present invention concerns a 4-hydroxy-2E-alkenoic acid according to formula (I) below
in which R is chosen in the group consisting of CH3-, CH3-(CH2)3- and CH3-(CH2)3-CH=CH- and its use as lipid peroxidation marker. The present invention also concerns methods to determine its presence and its level in solution and methods for the diagnosis of a pathology involving an increase in lipid peroxidation and for following the effectiveness of the treatment of said pathologies.
[EN] SPECIFIC MARKERS OF LIPID PEROXIDATION<br/>[FR] MARQUEURS SPECIFIQUES DE LA PEROXYDATION LIPIDIQUE
申请人:INST NAT SANTE RECH MED
公开号:WO2004035517A1
公开(公告)日:2004-04-29
The present invention concerns a 4-hydroxy-2Ealkenoic acid according to formula (I) below in which R is chosen in the group consisting of CH3-, CH3-(CH2)3- and CH3-(CH2)3-CH=CH- and its use as lipid peroxidation marker. The present invention also concerns methods to determine its presence and its level in solution and methods for the diagnosis of a pathology involving an increase in lipid peroxidation and for following the effectiveness of the treatment of said pathologies.
Total synthesis of (.+-.)-12-hydroxy-5,8,14-cis-10-trans-eicosatetraenoic acid (12-HETE)